BIOMAT Database Logo BIOMAT Database Logo

Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones. 2003

Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Dipartimento Farmaco-Chimico, Università di Messina, viale Annunziata 98168, Messina, Italy.

Several 1,3-thiazolidin-4-ones bearing a 2,6-dihalophenyl group at C-2 and a variously substituted phenyl ring at N-3 have been synthesized and tested as anti-HIV agents. The results of the in vitro tests showed that some of them proved to be effective inhibitors of HIV-1 replication.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Microwave-assisted synthesis and anti-YFV activity of 2,3-diaryl-1,3-thiazolidin-4-ones.
September 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Synthesis and biological evaluation of 2,3-diaryl substituted-1,3-thiazolidin-4-ones as anti-HIV agents.
July 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents.
July 2001, Bioorganic & medicinal chemistry letters,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
November 2002, Journal of medicinal chemistry,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Predicting anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones: computational approach using reformed eccentric connectivity index.
December 2004, Journal of molecular modeling,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. II. Biological activity of chlorinated 2,3-diaryl-1,3-thiazolidin-4-ones.
February 1989, Bollettino della Societa italiana di biologia sperimentale,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. III. Biological activity of halogenated 2,3-diaryl-1,3-thiazolidin-4-ones.
June 1989, Bollettino della Societa italiana di biologia sperimentale,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. IV. Biological activity of variously substituted 2,3-diaryl-1,3-thiazolidin-4-ones.
September 1989, Bollettino della Societa italiana di biologia sperimentale,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
December 2008, European journal of medicinal chemistry,
Angela Rao, and Anna Carbone, and Alba Chimirri, and Erik De Clercq, and Anna Maria Monforte, and Pietro Monforte, and Christophe Pannecouque, and Maria Zappalà
Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
February 2007, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!